Yuki Ito

Abstract #1244: Monotherapeutic and combination antitumor activities of TAK-701, a humanized anti-hepatocyte growth factor neutralizing antibody, against multiple types of cancer

O. Kitahara, T. Inaoka, Y. Misumi, 2009 .

Ribosomal protein S6 promotes stem‐like characters in glioma cells

N. Shinojima, A. Mukasa, H. Jono, 2020, Cancer science.

Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis

Y. Okuno, M. Matsuoka, H. Jono, 2021, Cancers.

Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers

T. Kurokawa, T. Kokubo, A. Hori, 2013, Molecular Cancer.

Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey

Yoko Tanaka, T. Kurokawa, T. Kokubo, 2018, PloS one.

Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers

Shuji Sato, T. Kurokawa, T. Kokubo, 2013, Molecular Cancer.